Compare PCRX & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | ASTE |
|---|---|---|
| Founded | 2006 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2011 | N/A |
| Metric | PCRX | ASTE |
|---|---|---|
| Price | $26.23 | $46.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | $32.86 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 723.2K | 181.4K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 1.12% |
| EPS Growth | N/A | N/A |
| EPS | 0.47 | ★ 2.08 |
| Revenue | $716,791,000.00 | ★ $1,368,800,000.00 |
| Revenue This Year | $6.24 | $8.19 |
| Revenue Next Year | $9.53 | $6.23 |
| P/E Ratio | $55.78 | ★ $22.38 |
| Revenue Growth | 3.14 | ★ 6.66 |
| 52 Week Low | $18.17 | $29.65 |
| 52 Week High | $27.64 | $50.83 |
| Indicator | PCRX | ASTE |
|---|---|---|
| Relative Strength Index (RSI) | 67.86 | 57.67 |
| Support Level | $25.17 | $43.77 |
| Resistance Level | $24.81 | $47.56 |
| Average True Range (ATR) | 0.96 | 1.46 |
| MACD | 0.26 | 0.38 |
| Stochastic Oscillator | 76.49 | 78.93 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.